252 related articles for article (PubMed ID: 33787840)
1. Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile Hemangioma.
Fernández Faith E; Shah S; Witman PM; Harfmann K; Bradley F; Blei F; Pope E; Alsumait A; Gupta D; Covelli I; Streicher JL; Cotton C; Tollefson M; Nguyen H; Hunt R; Moore-Clingenpeel M; Frieden IJ
JAMA Dermatol; 2021 May; 157(5):566-572. PubMed ID: 33787840
[TBL] [Abstract][Full Text] [Related]
2. Infantile hemangiomas, complications and treatments.
Cheng CE; Friedlander SF
Semin Cutan Med Surg; 2016 Sep; 35(3):108-16. PubMed ID: 27607318
[TBL] [Abstract][Full Text] [Related]
3. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.
Muñoz-Garza FZ; Ríos M; Roé-Crespo E; Bernabeu-Wittel J; Montserrat-García MT; Puig L; Gich I; Baselga E
JAMA Dermatol; 2021 May; 157(5):583-587. PubMed ID: 33825828
[TBL] [Abstract][Full Text] [Related]
5. Topical timolol maleate 0.5% for infantile hemangioma; it's effectiveness and/or adjunctive pulsed dye laser - single center experience of 102 cases in Korea.
Park KH; Jang YH; Chung HY; Lee WJ; Kim DW; Lee SJ
J Dermatolog Treat; 2015; 26(4):389-91. PubMed ID: 25424048
[TBL] [Abstract][Full Text] [Related]
6. Nd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children.
Hartmann F; Lockmann A; Grönemeyer LL; Haenssle HA; Zutt M; von Fintel H; Kühnle I; Schön MP; Thoms KM
J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1372-1379. PubMed ID: 27911476
[TBL] [Abstract][Full Text] [Related]
7. Incidence and clinical factors associated with ulceration in infantile hemangiomas.
Fernández Faith E; Shah SD; Braun M; Pope E; Lara-Corrales I; Witman PM; Harfmann K; Bradley F; Keesari R; Jackson K; Hallagan A; Frieden IJ
J Am Acad Dermatol; 2023 Feb; 88(2):414-420. PubMed ID: 36404484
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of adrenergic beta-antagonist combined with lasers in the treatment of infantile hemangiomas: a meta-analysis.
Chen X; Guo Y; Wang P; Qiu F; Sun Y; Shi Q; Deng Y; Hu C; Lei S
Pediatr Surg Int; 2020 Oct; 36(10):1135-1147. PubMed ID: 32647928
[TBL] [Abstract][Full Text] [Related]
9. Urgent Treatment of Complicated Ulcerated Infantile Hemangioma with β-Blockers via Telemedicine: A Case Report.
Bogomolets O; Wierzbik-Strońska M; Hryshchenko R; Bogomolets C
Telemed J E Health; 2024 Mar; 30(3):881-884. PubMed ID: 37651201
[No Abstract] [Full Text] [Related]
10. Infantile hemangioma. Part 2: Management.
Sebaratnam DF; Rodríguez Bandera AL; Wong LF; Wargon O
J Am Acad Dermatol; 2021 Dec; 85(6):1395-1404. PubMed ID: 34419523
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of ulcerated infantile hemangioma with brimonidine-timolol cream: 2 cases report and review of the literature.
Almebayadh M
J Dermatolog Treat; 2020 Jun; 31(4):433-434. PubMed ID: 30973791
[TBL] [Abstract][Full Text] [Related]
12. [Combination of pulsed dye laser and propranolol in the treatment of ulcerated infantile haemangioma].
Rodríguez-Ruiz M; Tellado MG; del Pozo Losada J
An Pediatr (Barc); 2016 Feb; 84(2):92-6. PubMed ID: 26002439
[TBL] [Abstract][Full Text] [Related]
13. Laser treatment of infantile hemangioma: A systematic review.
Chinnadurai S; Sathe NA; Surawicz T
Lasers Surg Med; 2016 Mar; 48(3):221-33. PubMed ID: 26711436
[TBL] [Abstract][Full Text] [Related]
14. Management of infantile hemangiomas-experience of a tertiary hospital.
Gomes R; Salazar L; Fraga C; Correia MR; Barbosa-Sequeira J; Fernandes A; Álvares S; Banquart Leitão J; Paiva Coelho M
Eur J Pediatr; 2023 Apr; 182(4):1611-1618. PubMed ID: 36705724
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of infantile hemangiomas with aggressive, persistent, and destructive ulceration.
Gautam A; Frieden IJ; Shah SD; Witman PM; Harfmann K; Bradley F; Blei F; Pope E; Alsumait A; Gupta D; Covelli I; Streicher JL; Cotton C; Tollefson M; Nguyen H; Hunt R; Buros A; Fernández Faith E
Pediatr Dermatol; 2023; 40(6):996-1002. PubMed ID: 37845188
[TBL] [Abstract][Full Text] [Related]
16. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
[TBL] [Abstract][Full Text] [Related]
17. [Response to oral propranolol therapy for ulcerated hemangiomas in infancy].
Michel JL; Patural H
Arch Pediatr; 2009 Dec; 16(12):1565-8. PubMed ID: 19892536
[TBL] [Abstract][Full Text] [Related]
18. Infantile Hemangiomas Cleared by Combined Therapy With Pulsed Dye Laser and Propranolol.
Sugimoto A; Aoki R; Toyohara E; Ogawa R
Dermatol Surg; 2021 Aug; 47(8):1052-1057. PubMed ID: 34397540
[TBL] [Abstract][Full Text] [Related]
19. Beta blocker treatment for infantile hemangiomas.
Rouhana HF; Fruge JH; Massengale WT
Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and safety of lasers, topical timolol, and combination therapy for the treatment of infantile hemangioma: A meta-analysis of 10 studies.
Huang H; Chen X; Cai B; Yu J; Wang B
Dermatol Ther; 2022 Dec; 35(12):e15907. PubMed ID: 36205218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
